Global Central Nervous System Drugs Market 2011-2015

Introduction

TechNavio's analysts forecast the Global Central Nervous System Drugs market to grow at a CAGR of -3.2 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing size of aging population. The Global EEG/EMG Equipment market has also been witnessing the trend of novel molecules, launched to treat central nervous system disorders effectively. However, patent expiration of key drugs could pose a challenge to the growth of this market.

TechNavio's report, the Global Central Nervous System Drugs Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Central Nervous System Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this market space include AstraZeneca plc, Eli Lilly & Co., Johnson & Johnson Ltd., and Pfizer Inc. Other vendors mentioned in the report: Abbott Laboratories, Sanofi S.A., Bristol-Myers Squibb Co., Eisai Co. Ltd., UCB Pharma, Merck & Co. Inc., Schering-Plough Corp., Shire plc, and Cephalon Inc.

Key questions answered in this report:

• What will the market size be in 2015 and at what rate will it grow?
• What key trends is this market subject to?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the opportunities and threats faced by each of these key vendors?
• What are the strengths and weaknesses of each of these key vendors?

You can request one free hour of analyst time when you purchase this report. Details provided within the report.

Table of Contents

01. Executive Summary

02. Introduction

03. Market Coverage

• Overview
• Product Offerings

04. Market Landscape

• Global Central Nervous System Drugs Market
• Market Size
• Key Market Segments

• 04.1. Global Antipsychotics Market
• 04.2. Global Antidepressants Market
• 04.3. Global Antiepileptic Drugs Market
• 04.4. Global Anti-Alzheimer's Drugs Market
• 04.5. Global ADHD Drugs Market
• 04.6. Global Hypnotics Market
• 04.7. Global Anti-Parkinson's Drugs Market

• 04.8. Global Antimigraine Drugs Market
  • Segmentation of Global Central Nervous System Drugs Market
  • Five Forces Analysis

05. Geographical Segmentation

06. Key Leading Countries

• USA
• Japan
• Germany

07. Rate of Incidence and Prevalence

08. Vendor Landscape

• Matrix of the Product Portfolio Matrix
• Vendor Landscape of the Leading CNS Drugs Market Segments

• 08.1. Global Antipsychotics Market Segment
• 08.2. Global Antidepressants Market Segment
• 08.3. Global Antiepileptic Drugs Market Segment

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Key Vendor Analysis

• 15.1. Eli Lilly and Co.
  • Business Overview
  • SWOT Analysis

• 15.2. Pfizer Inc.
  • Business Overview
  • SWOT Analysis

• 15.3. AstraZeneca plc
  • Business Overview
  • SWOT Analysis

• 15.4. Johnson and Johnson Ltd.
  • Business Overview
  • SWOT Analysis

16. Other Reports in this Series

• Exhibit 1: Global Central Nervous System Drugs Market 2011-2015 (US$ billion)
• Exhibit 2: Global Central Nervous System Drugs Market Segmentation 2011
• Exhibit 3: Global Central Nervous System Drugs Market by Product Segmentation 2011-2015 (percent)
• Exhibit 4: Global Antipsychotics Market 2011-2015 (US$ billion)
• Exhibit 5: Global Antidepressants Market 2011-2015 (US$ billion)
• Exhibit 6: Global Antiepileptic Drugs Market 2011-2015 (US$ billion)
• Exhibit 7: Global Anti-Alzheimer's Drugs Market 2011-2015 (US$ billion)
• Exhibit 8: Global Attention Deficit Hyperactivity Disorder Drugs Market 2011-2015 (US$ billion)
• Exhibit 9: Global Hypnotics Market 2011-2015 (US$ billion)
• Exhibit 10: Global Anti-Parkinson's Drugs Market 2011-2015 (US$ billion)
• Exhibit 11: Global Antimigraine Drugs Market 2011-2015 (US$ billion)
• Exhibit 12: Global Central Nervous System Market by Overall Market Segmentation (US$ billion)
• Exhibit 13: Global Central Nervous System Drugs Market by Geographical Segmentation 2011
• Exhibit 14: Global Central Nervous System Drugs Market by Vendor Segmentation 2011
• Exhibit 15: Global Antipsychotics Market by Vendor Segmentation 2011
• Exhibit 16: Global Antidepressants Market by Vendor Segmentation 2011
• Exhibit 17: Global Antiepileptic Drugs Market by Vendor Segmentation 2011

Global Central Nervous System Drugs Market 2011-2015 published by Infiniti Research Limited (Technavio) in July 13, 2012. This report consists of Pages: 56 and the price starts from US $ 2000.